NDC 50419-347 – Ultravist

Iopromide 300 mg/mL · Injection · Intra-arterial, Intravenous

Human Prescription Drug

Product NDC50419-347

Product details

Brand name
Ultravist
Generic name
iopromide
Labeler
Bayer HealthCare Pharmaceuticals Inc.
Dosage form
Injection
Route
Intra-arterial, Intravenous
Marketing category
NDA · NDA020220
Marketed since
June 8, 2022
Listing expires
December 31, 2027
Pharmacologic class
Radiographic Contrast Agent

Active ingredients

Uses, dosage, side effects and warnings for Ultravist →

Package NDC codes (2)

Package NDCDescriptionSince
50419-347-0550 mL in 1 VIAL, GLASS (50419-347-05)Jun 8, 2022
50419-347-20200 mL in 1 VIAL, GLASS (50419-347-20)Jun 8, 2022

Other Ultravist products